<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>112</id><JournalTitle>COMPENSATORY  STRATEGY  ON  TRANSDERMAL  DRUG  DELIVERY SYSTEMS</JournalTitle><Abstract>Transdermal drug delivery has made an advance contribution to medical practice, but it has yet to fully achieve its 
potential as an alternative to the oral delivery and hypodermic injections. An important of a transdermal drug delivery route
over other types of delivery systems such as oral, topical, intravenous, intramuscular, etc. is that the patch may essentially can
provide a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoi r 
of  medication or through body heat melting thin layers of medication embedded in the adhesive. First-generation transdermal 
delivery  systems  have  continued  their  steady  increase  in  clinical  use  for  delivery  of  small,  lipophilic,  low-dose  drugs. 
Transdermal delivery has many advantages over conventional modes of drug administrations, it thus avoids hepatic first pass 
metabolism and improves patient compliance. This approach of drug delivery is more permanent in case chronic disorders like 
hypertension which requires long term dosing to maintain therapeutic drug concentration. These systems are easy to apply and 
remove  as  when  desired.  Second-generation  delivery  systems  using  chemical  enhancers,  non-cavitational  ultrasound  and 
iontophoresis have also resulted in  clinical products; the ability of iontophoresis to control delivery rates in real time provides 
added  functionality.  Third-generation  delivery  systems  target  their  effects  to  skinâ€˜s  barrier  layer  of  stratum  corneum  using 
microneedles, thermal ablation, microdermabrasion, electroporation and cavitational ultrasound. Using  these novels  secondand  third-generation  enhancement  strategies,  transdermal  delivery  is  poised  to  significantly  increase  impact  on  medicine. 
Pharmaceutical scientists are striving to add  new deliverables to the short list of approved Transdermal products. The main 
aim  and  objective  of  Transdermal  drug  delivery  system  are  topical  administered  medicaments  in  the  form  of  patches  that 
deliver drugs for systemic effect at a predetermined and controlled rate. Transdermal systems deliver drugs direct through the 
skin</Abstract><Email>mehdinub@yahoo.com</Email><articletype>Review</articletype><volume>7</volume><issue>2</issue><year>2017</year><keyword>Transdermal  Drug  Delivery,Excipients,Skin  Permeation,Membrane  moderated  systems, Adhesive  diffusion  controlled system,Micro reservoir system,Animal Model</keyword><AUTHORS>Md.  Mehdi  Hasan,A.S.M.Aktar-Uz-Zaman,Md.  Mohshin  Islam,S.M.  Nazrul  Islam,Yousuf,Harun Ar Rashid</AUTHORS><afflication>Department of Pharmacy, Faculty of Life Science, University of Development Alternative, Dhaka-1209, Bangladesh,Department of Pharmacy, Faculty of Health science, Northern University Bangladesh, Dhaka -1205, Bangladesh,Department of Pharmacy, Faculty of Life Science, University of Development Alternative, Dhaka-1209, Bangladesh,Department of Pharmacy, Faculty of Health science, Northern University Bangladesh, Dhaka -1205, Bangladesh,Department of Pharmacy, Faculty of Health science, Northern University Bangladesh, Dhaka -1205, Bangladesh,Department of Pharmacy, Faculty of Health science, Northern University Bangladesh, Dhaka -1205, Bangladesh</afflication></Article></Articles>